PURPOSE Leading professional organizations acknowledge the importance of an informed decision-making process for prostate cancer screening. We describe primary care physicians' reports of their prescreening discussions about the potential harms and benefi ts of prostate cancer screening.
INTRODUCTION
T he US Preventive Services Task Force recently updated its recommendation about screening for prostate cancer to a D recommendation (the harms of screening for prostate cancer based on prostate-specifi c antigen [PSA] outweigh the benefi ts) while acknowledging that men will continue to request screening and physicians should engage their patients in making an informed choice. 1 The updated 2010 American Cancer Society guideline is more specifi c: asymptomatic men with at least a 10-year life expectancy should have an opportunity to make an informed decision with their clinician about prostate cancer screening, and screening should not occur without an informed decision-making process whereby the potential uncertainties, risks, and potential benefi ts are considered. 2 The latter recommendation in particular presents a challenge for primary care physicians within the context of the many competing demands in clinical practice. 3, 4 Although most primary care physicians
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screen for prostate cancer, 5 little is known about their use of prescreening discussions of the risks and benefi ts of screening 6 ; this knowledge is a key component of an informed decision-making process. [7] [8] [9] Using telephone focus groups, Purvis Cooper et al 10 explored the practice styles of primary care physicians regarding PSA testing and identifi ed 2 practice patterns: routine and nonroutine screening. Most physicians, more than 80%, were routine screeners, automatically ordering PSA tests for men aged 50 years and older with a 10-year life expectancy, without discussing the potential harms and benefi ts of testing. For routine screeners, this practice pattern was supported by personal and professional experience related to PSA testing, perceived patient expectation to be screened, a belief in scientifi c evidence showing benefi t from PSA testing, community norms favoring screening, awareness of American Cancer Society guidelines, belief that PSA testing is part of comprehensive medical care, and concerns about malpractice for not ordering the test. In contrast, one-fi fth of the physicians were described as nonroutine screeners, who did not automatically order PSA testing for their patients. Regardless of the practice pattern, all the physicians noted that they ultimately screened most of their eligible patients for prostate cancer. 10 The current study examines the use of prescreening discussions regarding the potential benefi ts and harms of prostate cancer screening by physicians in a large, national primary care research network. It further explores the role of physicians' beliefs about the effi cacy of prostate cancer screening and contextual factors related to whether they discuss these harms and benefi ts.
METHODS

Survey Participants
Study participants were physician members of the American Academy of Family Physicians National Research Network (AAFP NRN). Trainees were excluded. Established in 1999, the network is a voluntary research association of primary care clinicians who collaborate on studies to describe and improve primary care practice. Comparisons show that AAFP NRN members are similar to the broader AAFP membership on clinical practice variables, but they differ on percentage of time spent in direct patient care (lower among NRN members).
11
Survey Instrument
We used a single-item indicator from a previous study by our group 12 to classify responding AAFP NRN physician-members on the basis of their self-reported approach to prostate cancer screening for age-appropriate men with no other risk factors. The 5 approaches were as follows: (1) order the PSA test without discussing the potential harms and benefi ts (screen without discussion); (2) discuss the harms and benefi ts and then recommend the test (discuss, recommend screening); (3) discuss the harms and benefi ts and then let the patient decide (discuss, let patient decide); (4) discuss the harms and benefi ts and then recommend against the test (discuss, recommend against); and (5) neither discuss the harms and benefi ts nor order the test (don't discuss or recommend). An "other" category was also included. We had previously determined that the practice style indicator had good criterion-related validity against reported prostate cancer-screening rates. 12 We then drafted statements espousing prostate cancer-screening-related beliefs to refl ect the primary and secondary themes identifi ed by Purvis Cooper et al 10 and other themes found in the literature. A 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree) was used for each indicator. The questionnaire was assessed for overall layout, fl ow, clarity, and time to administer. Redundant indicators were combined, and poorly worded indicators were dropped. A core set of 17 belief indicators was retained for the fi nalized survey (see Suplemental Appendix, available at http://annfammed.org/ content/11/1/67/suppl/DC1).
Information on the number of years in practice, sex, and clinical practice type (academically affi liated) for each responding physician was obtained from the NRN membership survey conducted by the AAFP.
Data Collection
Data collection was launched in July 2007 with the fi nal reminder mailed in January 2008. We used a 2-pronged strategy for data collection: e-mail and postal mail. If an e-mail address was available, an invitation was e-mailed to the member from the AAFP NRN research offi ce that contained an electronic link to the online survey. The link uniquely identifi ed each member for tracking purposes. Two e-mail reminders were sent at 3-week intervals to nonrespondents. The second strategy targeted members without e-mail addresses, whose e-mail invitation was returned undeliverable, or who did not complete the online version. Letters of invitation from the network director were posted to these members along with a copy of the questionnaire and a self-addressed postage-paid return envelope. One reminder letter with the questionnaire and a return envelope was sent to nonrespondents. By participating in the study (returning the mailed questionnaire or answering questions online) the physicians consented to the study. This study was reviewed and 
Statistical Analysis
Two coding schemes were used in our analysis of the physicians' responses regarding the belief indicators on prostate cancer-screening practices. The fi rst was the 5-point Likert scale, ranging from 1 (strongly disagree) to 5 (strongly agree). The second was an either-or coding system: Likert scale responses 1, 2, and 3 were coded as not endorsing the belief; responses 4 and 5 were coded as endorsing the belief. All belief indicator responses were retained in their original direction and orientation and were not reverse coded to create uniform indicator interpretations as, for example, supportive of or antagonistic to a particular screening practice style.
Bivariate statistics in the form of χ 2 or Fisher exact tests were calculated between the practice style indicator, physician characteristics, and each belief indicator. Physician characteristics and belief indicators displaying a relationship with practice style (P <.10) were retained in multivariate, multinomial, logistic regression modeling.
Multivariate, multinomial, logistic regression modeling was conducted using practice style as each model's dependent variable and the belief indicators as the primary independent variables. The physician characteristic variables of sex and years in medical practice, as well as academically affi liated practice, were treated as control variables and retained in all models tested. Models were then confi gured and tested after omitting, one at a time, belief indicators with nonsignifi cant effects in relation to physician prostate cancer-screening practice style.
Models were assessed in 3 ways for overall adequacy of fi t. A χ 2 -based -2 log-likelihood test was conducted to compare a model estimated to a null model (intercept only); P <.05 indicated adequate model prediction. Nominal group classifi cation accuracy was also assessed. Finally, using Nagelkerke's pseudo R 2 statistic, an estimate of the proportion of variance explained by a model was obtained. Final models provided odds ratio estimates per belief indicator; the preselected referent was the physicians' group reporting a practice style of discuss, let patient decide.
RESULTS
Study Flow and Population
Our 2-pronged (e-mail and postal mail) sampling strategy resulted in an overall participation rate of 57.7% (246 of 426 members; Figure 1 ). About 43% of questionnaires were completed online; 57% were completed and returned by mail. Nearly one-half of the respondents to the online survey were from academically affi liated practices compared with about one-third of respondents to the mailed survey (P = .037). Physicians in our study had been in practice for a slightly longer period of time but were otherwise similar to physicianmembers responding to the NRN membership survey (Table 1) .
Physicians' Prostate Cancer-Screening Practice Styles
Three physicians did not respond to questions about their practice style for prostate cancer screening, leaving 243 questionnaires for further analysis. Nearly one-half of the 243 physicians discussed screening and let their patients decide about testing, almost one-fourth discussed and recommended testing, and another one-fourth ordered the test without discus- Figure 2 ). The remaining 5% of respondents discussed and recommended against the PSA test, neither discussed it nor recommended it, or selected the "other" response option.
For subsequent analysis, we retained only the 3 most reported practice styles (n = 230 physicians): discuss, recommend screening; discuss, let patient decide; and screen without discussion.
Beliefs About Screening and Physician Practice Styles
The mean length of time in practice did not differ signifi cantly across the 3 most common practice styles: screen without discussion, 21.4 years (SD = 7.3 years); discuss, then recommend, 19.5 years (SD = 11.3 years); discuss, let patient decide, 19.3 years (SD = 8.5 years); P = .148). The distributions of other physician characteristics and responses to the belief indicators across the 3 selected practice styles are shown in Table 2 . The distribution of sex did not differ signifi cantly across the practice styles. Compared with physicians who discussed the potential harms and benefi ts of prostate cancer screening and either recommended the test or let the patient decide, physicians who screen patients without discussion were less likely to practice at an academically affi liated site. Fifteen of the 17 belief indicators were signifi cantly associated with practice style ( Table 2 ). The 2 nonsignifi cant belief indicators were in regard to professional experience with prostate cancer and personal experience with the disease.
Results From Multinomial, Logistic Regression Modeling
Physicians endorsing discuss, let patient decide were compared with physicians who endorsed screen without discussion and then physicians who endorsed discuss, recommend screening. The fi nal multinomial logistic regression model included 7 belief indicators, each of which had a signifi cant independent effect ( Table 3 ). The effects were adjusted for years in practice, sex of physician, and clinical practice type (academically affi liated practice). The model had favorable fi t characteristics: adequate model prediction compared with the null model (P <.001), adequate group classifi cation (across-group average was 76.6%), and a high proportion of variance explained by the model (Nagelkerke pseudo R 2 = 0.67). The style-specifi c signifi cance of the belief indicators varied by which practice styles were compared (Table 3) . Compared with physicians who ordered PSA testing without discussion, physicians who reported discussing the harms and benefi ts and then letting their patients decide about screening were more likely to endorse beliefs that scientifi c evidence does not support routine screening, that patients should be told about the lack of evidence, and that patients have a right to know the implications of screening. These physicians were also less likely to endorse the belief that there was no need to educate patients because the patients want to be screened. On the other hand, compared with physicians who discussed and then recommended screening, physicians who discussed and let their patients decide were more likely to endorse the idea that scientifi c evidence does not support screening; they were also less likely to endorse the beliefs that not screening puts a physician at medicolegal risk, that the benefi ts of screening outweighed the risks, and that the evidence clearly indicates that screening saves lives.
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DISCUSSION
In this study of physician members of the AAFP NRN, we observed considerable variability in self-reported approaches to engaging patients in discussions about the harms and benefi ts of prostate cancer screening and how decisions are made. Many physicians appear to order PSA testing for asymptomatic men within the recommended age range for screening without fi rst discussing the potential harms and benefi ts of testing with their patients. There is another, larger, group of physicians who report engaging patients who are candidates for prostate cancer screening in discussions about the harms and benefi ts, but these physicians differed in the degree to which they encourage patient autonomy in making the decision. Some of the physicians recommend screening, and others let the patient decide. This distinction is important, as it suggests that some physicians, while attempting to use an informed decision-making process, may actually be using an informed consent process involving a discussion of risks but still wanting their patients screened. Whether these physicians consider their practice style consistent with screening guidelines would be an interesting question to explore.
Physicians who reported engaging patients in prescreening discussions of the harms and benefi ts of PSA testing and allowing their patients to decide differed from physicians who reported other practice styles in several important ways. First, the belief about scientifi c evidence not supporting routine screening was more likely to be endorsed by the former group than the latter. With the subsequent release of the large European Randomized Study of Screening for Prostate Cancer (ERSPC), 13 US Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial results, 14 and several recent systematic reviews, 15, 16 the belief that scientifi c evidence does support routine screening may continue to be challenged. Yet, it is unclear whether the trial evidence or changes in guidelines will have a major impact on prostate cancer-screening rates. 17, 18 Second, the beliefs that patients should be told about the lack of evidence supporting screening and that patients have a right to know this information were more often endorsed by the physicians who discuss and let patients decide than by the physicians who order the PSA test outright. Conversely, physicians who ordered the test without discussion were more likely to believe that their patients want testing and that education is not needed. These observations offer an interesting juxtaposition of concerns about patient autonomy and the right to know important medical information and the pragmatic argument that education has no impact on screening preferences. A focus Effects are adjusted for years in practice, sex of physician, and academically affi liated practice. Dashes are used for nonsignifi cant beliefs indicators.
a Belief indicators are scored as endorsed (ie, agree or strongly agree) or not endorsed (neutral, disagree, or strongly disagree).
b Interpreted as the ratio of the odds of endorsing a belief indicator among physicians who reported a prostate cancer screening practice style of discuss, let patient decide vs the odds of endorsing the same belief indicator among physicians who reported the practice style of screen without discussion (fi rst column) or discuss, recommend screening (second column).
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on the decision as opposed to the decision-making process appears to distinguish these 2 practice styles. Finally, there is the provocative fi nding that physicians who discuss the harms and benefi ts and recommend the test more often endorsed concerns about the medicolegal risk associated with not screening compared with physicians who discuss and let the patient decide. These concerns have been highlighted by others and appear to have some impact on PSA testing rates. [19] [20] [21] Patient decision aids may be one solution for physicians who believe limited time with a patient is a barrier to the informed decision-making process and for those who have concerns about the medicolegal risks of not routinely screening men. Decision aids used before the clinical encounter may prepare patients for the informed decision-making process and lessen the process burden on the physician. In a study using mock trials, Barry and colleagues 22 found that almost all jurors agreed that a physician who provides an aid and documents that the patients has reviewed the aid in the medical chart would meet the standard of care. Some legal opinions suggest that a shared decision-making process using decision aids may also help "satisfy the legal requirements of disclosure of risks, benefi ts, and alternatives," and also establish a higher burden of proof for patients who attempt to claim that they were not adequately informed of risks or alternatives. 23 Despite a participation rate similar to that from other surveys of the AAFP NRN membership, 11 our study has several limitations. We do not know how well the reported practice styles related to actual physician-patient interactions and to the use of an informed decision-making process, and we might expect that discussions about prostate cancer screening occur less frequently than physicians reported. 24 Our study was limited to family physicians, so the applicability of the fi ndings to other clinicians (eg, general internists and nurse practitioners) is not known. Another limitation of the survey was that we did not ask physicians whether they used patient decision aids. Finally, we conducted the survey before the results of the ERSPC 14 and the US PLCO Cancer Screening Trial 13 were published in March 2009, which showed minimal mortality benefi t from screening (only in the European trial) and raised increasing concerns about overdetection of prostate cancer.
We observed considerable variability in primary care physicians' use of an informed decision-making process for prostate cancer screening. Much of the variability in these practice styles can be attributed to beliefs about screening, and some of these beliefs may be amenable to change. Currently, there are few negative sequelae for physicians who routinely screen patients for prostate cancer. 25 As the scientifi c evidence continues to grow regarding the limited benefi ts of screening with PSA testing and practice guidelines more strongly recommend preference-based decision making, we may expect physicians who do not engage their patients in discussions about the potential harms and benefi ts of screening to consider changing their practice styles. Efforts to educate physicians about the shared decision-making process should include countering the beliefs that perpetuate routine screening. 
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